카나비노이드 시장 규모, 점유율, 동향 및 성장 분석 보고서(2026-2034년)

The global cannabinoids market size is expected to reach USD 115.07 Billion in 2034 from USD 30.90 Billion in 2025, growing at a CAGR of 15.73% during 2026-2034.The paper coating materials market has expanded alongside demand for premium printing finishes, e-commerce packaging, and functional barrier papers for food and pharmaceutical use. Growth has been propelled by brand owners seeking better print quality and protective properties-gloss, grease resistance, and moisture barriers-while converters and paper mills invest in coating lines that enable higher-speed production and tighter quality control. Digital and specialty printing segments also contribute to steady demand for advanced coatings.

Primary drivers include sustainability mandates and regulatory pressure to reduce plastic laminates, which spur R&D into recyclable, compostable, and water-based coatings. Growth in food and beverage packaging, increasing online retail shipments, and the need for grease- and moisture-resistant barrier solutions push adoption. Innovations such as bio-based binders and mineral-loaded coatings further broaden application scope and performance, while regional raw-material availability shapes cost dynamics.

Looking forward, the market's prospects will center on balancing performance with circularity: suppliers that deliver recyclable-compatible coatings, low-emission processes, and validated life-cycle benefits will lead. Niche expansion in functional and smart coatings-antimicrobial layers, sensor-ready surfaces, and print-compatible coatings for high-resolution graphics-will create premium segments. Overall growth is likely moderate as mature markets stabilize but emerging economies and sustainability-driven product shifts provide durable tailwinds.

Our reports are carefully developed to deliver comprehensive and actionable insights across a wide range of industries and markets. Each report includes several essential components designed to provide a complete understanding of the market environment:

Market Overview: This section provides a clear introduction to the market, including key definitions, classifications, and an overview of the current industry landscape.

Market Dynamics: A detailed evaluation of the primary drivers, restraints, opportunities, and challenges shaping market growth. It covers factors such as technological developments, regulatory frameworks, and evolving industry trends.

Segmentation Analysis: A structured breakdown of the market into key segments based on product type, application, end-user, and geographic region. This section highlights the performance, growth potential, and contribution of each segment.

Competitive Landscape: An in-depth assessment of leading market participants, including their market positioning, product portfolios, strategic initiatives, and financial performance. It provides valuable insights into competitive dynamics and the strategies adopted by key players.

Market Forecast: Data-driven projections of market size and growth patterns over a defined forecast period. This section incorporates historical trends, current market conditions, and quantitative analysis to illustrate expected future developments.

Regional Analysis: A comprehensive review of market performance across major geographic regions, identifying high-growth areas and regional trends to better understand localized market opportunities.

Emerging Trends and Opportunities: Identification of significant market trends, technological advancements, and new investment opportunities. This section highlights potential growth areas and future industry developments.

Customization Options: We offer flexible customization services to tailor reports according to specific client requirements. This may include additional segmentation, country-level analysis, competitor profiling, customized data points, or focused insights on particular market segments to better support strategic decision-making.

MARKET SEGMENTATION

By Product Type

• Cannabidiol
• Tetrahydrocannabinol
• Cannabinol
• Others

By Application

• Medicinal Use (Chronic Pain, Neurological Disorders Management, Oncology, Others)
• Non-medical Use

By Distribution Channel

• Hospital Pharmacies
• Retail Pharmacies
• Online Stores

COMPANIES PROFILED

• Mylan N.V. (Viatris Inc.), Alkem Labs, GW Pharmaceuticals plc (Jazz Pharmaceuticals), Tilray Inc., Aurora Cannabis Inc., Canopy Growth Corporation, The Cronos Group, Endoca, Cannoid LLC, Medical Marijuana Inc.

TABLE OF CONTENTS

Chapter 1. PREFACE

• 1.1. Market Segmentation & Scope
• 1.2. Market Definition
• 1.3. Information Procurement
  • 1.3.1 Information Analysis
  • 1.3.2 Market Formulation & Data Visualization
  • 1.3.3 Data Validation & Publishing
• 1.4. Research Scope and Assumptions
  • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

• 2.1. Market Snapshot
• 2.2. Segmental Outlook
• 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

• 3.1. Market Lineage Outlook
• 3.2. Penetration & Growth Prospect Mapping
• 3.3. Value Chain Analysis
• 3.4. Regulatory Framework
  • 3.4.1 Standards & Compliance
  • 3.4.2 Regulatory Impact Analysis
• 3.5. Market Dynamics
  • 3.5.1 Market Drivers
  • 3.5.2 Market Restraints
  • 3.5.3 Market Opportunities
  • 3.5.4 Market Challenges
• 3.6. Porter's Five Forces Analysis
• 3.7. PESTLE Analysis

Chapter 4. GLOBAL CANNABINOIDS MARKET: BY PRODUCT TYPE 2022-2034 (USD MN)

• 4.1. Market Analysis, Insights and Forecast Product Type
• 4.2. Cannabidiol Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.3. Tetrahydrocannabinol Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.4. Cannabinol Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.5. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL CANNABINOIDS MARKET: BY APPLICATION 2022-2034 (USD MN)

• 5.1. Market Analysis, Insights and Forecast Application
• 5.2. Medicinal Use (Chronic Pain, Neurological Disorders Management, Oncology, Others) Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.3. Non-medical Use Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL CANNABINOIDS MARKET: BY DISTRIBUTION CHANNEL 2022-2034 (USD MN)

• 6.1. Market Analysis, Insights and Forecast Distribution Channel
• 6.2. Hospital Pharmacies Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.3. Retail Pharmacies Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.4. Online Stores Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL CANNABINOIDS MARKET: BY REGION 2022-2034 (USD MN)

• 7.1. Regional Outlook
• 7.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.2.1 By Product Type
  • 7.2.2 By Application
  • 7.2.3 By Distribution Channel
  • 7.2.4 United States
  • 7.2.5 Canada
  • 7.2.6 Mexico
• 7.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.3.1 By Product Type
  • 7.3.2 By Application
  • 7.3.3 By Distribution Channel
  • 7.3.4 United Kingdom
  • 7.3.5 France
  • 7.3.6 Germany
  • 7.3.7 Italy
  • 7.3.8 Russia
  • 7.3.9 Rest Of Europe
• 7.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.4.1 By Product Type
  • 7.4.2 By Application
  • 7.4.3 By Distribution Channel
  • 7.4.4 India
  • 7.4.5 Japan
  • 7.4.6 South Korea
  • 7.4.7 Australia
  • 7.4.8 South East Asia
  • 7.4.9 Rest Of Asia Pacific
• 7.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.5.1 By Product Type
  • 7.5.2 By Application
  • 7.5.3 By Distribution Channel
  • 7.5.4 Brazil
  • 7.5.5 Argentina
  • 7.5.6 Peru
  • 7.5.7 Chile
  • 7.5.8 Rest of Latin America
• 7.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.6.1 By Product Type
  • 7.6.2 By Application
  • 7.6.3 By Distribution Channel
  • 7.6.4 Saudi Arabia
  • 7.6.5 UAE
  • 7.6.6 Israel
  • 7.6.7 South Africa
  • 7.6.8 Rest of the Middle East And Africa

Chapter 8. COMPETITIVE LANDSCAPE

• 8.1. Recent Developments
• 8.2. Company Categorization
• 8.3. Supply Chain & Channel Partners (based on availability)
• 8.4. Market Share & Positioning Analysis (based on availability)
• 8.5. Vendor Landscape (based on availability)
• 8.6. Strategy Mapping

Chapter 9. COMPANY PROFILES OF GLOBAL CANNABINOIDS INDUSTRY

• 9.1. Top Companies Market Share Analysis
• 9.2. Company Profiles
  • 9.2.1 Mylan N.V. (Viatris Inc.)
  • 9.2.2 Alkem Labs
  • 9.2.3 GW Pharmaceuticals Plc (Jazz Pharmaceuticals)
  • 9.2.4 Tilray Inc
  • 9.2.5 Aurora Cannabis Inc
  • 9.2.6 Canopy Growth Corporation
  • 9.2.7 The Cronos Group
  • 9.2.8 Endoca
  • 9.2.9 Cannoid LLC
  • 9.2.10 Medical Marijuana Inc